Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 3631 AL 3645

Mitochondrial Dysfunction in Huntington's Disease: Pathogenesis and Therapeutic Opportunities

Sharma A, Behl T, Sharma L, Aelya L, Bungau S.

Curr Drug Targets. 2021;22(14):1637-1667. doi: 10.2174/1389450122666210224105945.

Clinical variables that help in predicting the presence of autoantibodies in patients with acute encephalitis

Lizcano-Meneses A, Watanabe N, von Glehn F, Barbosa R, de Albuquerque M, Yassuda C, Moraes AS, Martínez JW, Santos LMB, Cendes F.

Seizure. 2021 Aug;90:117-122. doi: 10.1016/j.seizure.2021.02.023. Epub 2021 Feb 24.

hiPSCs for predictive modelling of neurodegenerative diseases: dreaming the possible

Rivetti di Val Cervo P, Besusso D, Conforti P, Cattaneo E.

Nat Rev Neurol. 2021 Jun;17(6):381-392. doi: 10.1038/s41582-021-00465-0. Epub 2021 Mar 3.

In silico designing of putative peptides for targeting pathological protein Htt in Huntington's disease

Kohli H, Kumar P, Ambasta RK.

Heliyon. 2021 Feb 12;7(2):e06088. doi: 10.1016/j.heliyon.2021.e06088. eCollection 2021 Feb.

Digital Technology in Movement Disorders: Updates, Applications, and Challenges

Adams JL, Lizarraga KJ, Waddell EM, Myers TL, Jensen-Roberts S, Modica JS, Schneider RB.

Curr Neurol Neurosci Rep. 2021 Mar 3;21(4):16. doi: 10.1007/s11910-021-01101-6.

Deletion of conserved non-coding sequences downstream from NKX2-1: A novel disease-causing mechanism for benign hereditary chorea

Liao J, Coffman KA, Locker J, Padiath QS, Nmezi B, Filipink RA, Hu J, Sathanoori M, Madan-Khetarpal S, McGuire M, Schreiber A, Moran R, Friedman N, Hoffner L, Rajkovic A, Yatsenko SA, Surti U.

Mol Genet Genomic Med. 2021 Apr;9(4):e1647. doi: 10.1002/mgg3.1647. Epub 2021 Mar 5.

Essential Oils as a Potential Neuroprotective Remedy for Age-Related Neurodegenerative Diseases: A Review

Abd Rashed A, Abd Rahman AZ, Rathi DNG.

Molecules. 2021 Feb 19;26(4):1107. doi: 10.3390/molecules26041107.

Regenerative Stem Cell Therapy for Neurodegenerative Diseases: An Overview

Sivandzade F, Cucullo L.

Int J Mol Sci. 2021 Feb 22;22(4):2153. doi: 10.3390/ijms22042153.

Neuroprotection with Bacopa monnieri-A review of experimental evidence

Shalini VT, Neelakanta SJ, Sriranjini JS.

Mol Biol Rep. 2021 Mar;48(3):2653-2668. doi: 10.1007/s11033-021-06236-w. Epub 2021 Mar 6.

Case Report: Chorea-Acanthocytosis Presents as Epilepsy in a Consanguineous Family With a Nonsense Mutation of in VPS13A

Luo FM, Deng MX, Yu R, Liu L, Fan LL.

Front Neurosci. 2021 Feb 10;15:604715. doi: 10.3389/fnins.2021.604715. eCollection 2021.

Clinical development of valbenazine for tics associated with Tourette syndrome

Farber RH, Angelov A, Kim K, Carmack T, Thai-Cuarto D, Roberts E.

Expert Rev Neurother. 2021 Apr;21(4):393-404. doi: 10.1080/14737175.2021.1898948. Epub 2021 Apr 1.

Donor-containing cortical and intraventricular glioneuronal nodules in Huntington's disease brain decades after fetal cell transplantation

Pinarbasi ES, Liu EA, Yu Z, Kopyov O, Brown NA, Dayalu P, Lieberman AP.

Acta Neuropathol. 2021 Jun;141(6):979-981. doi: 10.1007/s00401-021-02292-5. Epub 2021 Mar 8.

Cerebral venous thrombosis, neutropenia and iron-deficiency anemia in Huntington disease

Tabibian F, Adibi I, Ardestani PE, Tabibian E, Akbaripour S, Bürk K.

Neurodegener Dis Manag. 2021 Apr;11(2):137-142. doi: 10.2217/nmt-2020-0045. Epub 2021 Mar 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias